↓ Skip to main content

Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy

Overview of attention for article published in Pharmaceutics, November 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
Published in
Pharmaceutics, November 2021
DOI 10.3390/pharmaceutics13111959
Pubmed ID
Authors

Maria Arista-Romero, Anna Cascante, Cristina Fornaguera, Salvador Borrós

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 25%
Student > Master 2 13%
Other 1 6%
Student > Bachelor 1 6%
Lecturer 1 6%
Other 2 13%
Unknown 5 31%
Readers by discipline Count As %
Unspecified 4 25%
Biochemistry, Genetics and Molecular Biology 2 13%
Chemical Engineering 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Physics and Astronomy 1 6%
Other 0 0%
Unknown 7 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2021.
All research outputs
#16,160,214
of 25,541,640 outputs
Outputs from Pharmaceutics
#2,286
of 6,565 outputs
Outputs of similar age
#266,333
of 515,079 outputs
Outputs of similar age from Pharmaceutics
#169
of 489 outputs
Altmetric has tracked 25,541,640 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,565 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,079 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 489 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.